Literature DB >> 21927997

Pretreatment and posttreatment radiography in patients with pulmonary tuberculosis with and without human immunodeficiency virus infection.

Wirana Angthong1, Chayanin Angthong, Vithya Varavithya.   

Abstract

PURPOSE: The purpose of this study was to determine differences in pretreatment and posttreatment radiographic findings in pulmonary tuberculosis (PTB) patients with and without human immunodeficiency virus (HIV) infection.
MATERIALS AND METHODS: All patients were reviewed in terms of pre- and posttreatment radiographic findings comparing non-HIV-related versus HIV-related PTB.
RESULTS: Among 177 PTB patients, 38 (22%) were HIV seropositive and 139 (78%) were HIV-seronegative. The most common radiographic finding in non-HIV-related TB was reticular infiltration (66.2%), whereas the miliary pattern was the most common radiographic finding in HIV-related TB (34.2%). Radiographic findings in HIV related TB significantly presented with higher prevalence of the miliary pattern (P < 0.0001) and lower prevalence of reticular infiltration (P < 0.0001), cavitation (P = 0.003), and mass-like lesions (P = 0.039) compared to non-HIV-related TB. During the posttreatment period, normal chest radiographs were significantly present in the patients who had HIV-seropositivity, the miliary pattern, and sputum negative for acid-fast bacilli during the pretreatment period (P < 0.05).
CONCLUSION: Pretreatment radiographic features of HIV-related TB had a significantly higher prevalence of the miliary pattern and lower prevalence of reticular infiltration, cavitation, and mass-like lesions. HIV-related TB and the miliary pattern seen by pretreatment radiography were significantly associated with normal chest radiographs during the posttreatment period.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927997     DOI: 10.1007/s11604-011-0597-3

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  22 in total

Review 1.  Pulmonary tuberculosis: the essentials.

Authors:  A N Leung
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

Review 2.  Pulmonary tuberculosis: up-to-date imaging and management.

Authors:  Yeon Joo Jeong; Kyung Soo Lee
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

3.  Radiographic alterations in patients presenting human immunodeficiency virus/tuberculosis coinfection: correlation with CD4+ T cell counts.

Authors:  Rosemeri Maurici da Silva; Lígia da Rosa; Renata Nunes Lemos
Journal:  J Bras Pneumol       Date:  2006 May-Jun       Impact factor: 2.624

4.  Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear.

Authors:  F Palmieri; E Girardi; A M Pellicelli; A Rianda; E Bordi; E Busi Rizzi; N Petrosillo; G Ippolito
Journal:  Infection       Date:  2002-04       Impact factor: 3.553

5.  Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation.

Authors:  J Batungwanayo; H Taelman; R Dhote; J Bogaerts; S Allen; P Van de Perre
Journal:  Am Rev Respir Dis       Date:  1992-07

6.  Cavitary pulmonary tuberculosis HIV-related.

Authors:  Elisa Busi Rizzi; Vincenzo Schininà; Fabrizio Palmieri; Enrico Girardi; Corrado Bibbolino
Journal:  Eur J Radiol       Date:  2004-11       Impact factor: 3.528

7.  Clinical and radiographic features of HIV-related pulmonary tuberculosis according to the level of immunosuppression.

Authors:  Guilherme Freire Garcia; Alexandre Sampaio Moura; Cid Sérgio Ferreira; Manoel Otávio da Costa Rocha
Journal:  Rev Soc Bras Med Trop       Date:  2007 Nov-Dec       Impact factor: 1.581

8.  Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Authors:  J Lucian Davis; William Worodria; Harriet Kisembo; John Z Metcalfe; Adithya Cattamanchi; Michael Kawooya; Rachel Kyeyune; Saskia den Boon; Krista Powell; Richard Okello; Samuel Yoo; Laurence Huang
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

9.  CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection.

Authors:  M D Keiper; M Beumont; A Elshami; C P Langlotz; W T Miller
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

10.  Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance).

Authors:  S D Greenberg; D Frager; B Suster; S Walker; C Stavropoulos; A Rothpearl
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

View more
  4 in total

Review 1.  A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.

Authors:  Jamilah Meghji; Hope Simpson; S Bertel Squire; Kevin Mortimer
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

2.  Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.

Authors:  James C M Brust; Andrew R Berman; Benjamin Zalta; Linda B Haramati; Yuming Ning; Moonseong Heo; Theo L van der Merwe; Sheila Bamber; Anthony P Moll; Gerald H Friedland; N Sarita Shah; Neel R Gandhi
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

3.  Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Authors:  Gambo Aliyu; Samer S El-Kamary; Alash'le Abimiku; Laura Hungerford; Joshua Obasanya; William Blattner
Journal:  BMC Infect Dis       Date:  2014-12-13       Impact factor: 3.090

4.  Chronic lung disease in HIV-infected children established on antiretroviral therapy.

Authors:  Jamie Rylance; Grace Mchugh; John Metcalfe; Hilda Mujuru; Kusum Nathoo; Stephanie Wilmore; Sarah Rowland-Jones; Edith Majonga; Katharina Kranzer; Rashida A Ferrand
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.